← Leaderboards
Florence Burleson
$4,647,424
Attributed
$4,647,424
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,647,424 · 1
By mechanism
N01$4,647,424 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Immune Function”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Yunda Huang · Fred Hutchinson Cancer Center$71,262,090
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$31,478,763
- Wilton B Williams · Duke University$16,226,847
- Gary Fanger · Rise Therapeutics, Llc$14,132,211
- Jeremy James Martinson · University Of Pittsburgh At Pittsburgh$14,031,836
Research focus
Immune FunctionImmunologicsFood AdditivesExposure ToImmune System FunctionHypersensitivityEnvironmental AgentCytokineEventExposed Human PopulationEnvironmental Risk FactorImmuneHealth HazardsHematopoieticDermalCell-Mediated CytolysisAutoimmune DiseasesChemical AgentsCommunicable DiseasesContractsCovid-19Dietary SupplementsAnimalsImmunologic Techniques
Grant awards (5)
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19$250,000
N01 · FY2025 · HD · contact PI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19$1,377,353
N01 · FY2024 · ES · contact PI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19$1,090,900
N01 · FY2023 · ES · contact PI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19$935,642
N01 · FY2022 · ES · contact PI
Enabling risk-based testing through characterization of environmentally-Induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19$993,529
N01 · FY2021 · ES · contact PI